Annual EBITDA
-$52.79 M
+$12.04 M+18.57%
December 31, 2024
Summary
- As of March 10, 2025, OCGN annual EBITDA is -$52.79 million, with the most recent change of +$12.04 million (+18.57%) on December 31, 2024.
- During the last 3 years, OCGN annual EBITDA has risen by +$5.01 million (+8.67%).
- OCGN annual EBITDA is now -268.38% below its all-time high of -$14.33 million, reached on December 31, 2012.
Performance
OCGN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$13.24 M
-$603.00 K-4.77%
December 31, 2024
Summary
- As of March 10, 2025, OCGN quarterly EBITDA is -$13.24 million, with the most recent change of -$603.00 thousand (-4.77%) on December 31, 2024.
- Over the past year, OCGN quarterly EBITDA has stayed the same.
- OCGN quarterly EBITDA is now -206.59% below its all-time high of $12.42 million, reached on December 31, 2019.
Performance
OCGN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$52.79 M
-$1.90 M-3.73%
December 31, 2024
Summary
- As of March 10, 2025, OCGN TTM EBITDA is -$52.79 million, with the most recent change of -$1.90 million (-3.73%) on December 31, 2024.
- Over the past year, OCGN TTM EBITDA has stayed the same.
- OCGN TTM EBITDA is now -1179.42% below its all-time high of -$4.13 million, reached on September 30, 2013.
Performance
OCGN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
OCGN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.6% | 0.0% | 0.0% |
| 3 y3 years | +8.7% | 0.0% | 0.0% |
| 5 y5 years | -186.7% | 0.0% | 0.0% |
OCGN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.4% | -16.7% | +53.0% | -4.5% | +42.9% |
| 5 y | 5-year | -186.7% | +40.4% | -206.6% | +53.0% | -956.6% | +42.9% |
| alltime | all time | -268.4% | +40.4% | -206.6% | +53.0% | -1179.4% | +42.9% |
Ocugen EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$52.79 M(-18.6%) | -$13.24 M(+4.8%) | -$52.79 M(+3.7%) |
| Sep 2024 | - | -$12.64 M(-15.0%) | -$50.89 M(+0.8%) |
| Jun 2024 | - | -$14.87 M(+23.5%) | -$50.51 M(-14.4%) |
| Mar 2024 | - | -$12.04 M(+6.1%) | -$59.00 M(-9.0%) |
| Dec 2023 | -$64.83 M(-26.8%) | -$11.35 M(-7.4%) | -$64.83 M(-20.6%) |
| Sep 2023 | - | -$12.25 M(-47.6%) | -$81.66 M(-11.6%) |
| Jun 2023 | - | -$23.37 M(+30.8%) | -$92.39 M(+4.4%) |
| Mar 2023 | - | -$17.86 M(-36.6%) | -$88.49 M(-0.1%) |
| Dec 2022 | -$88.59 M(+53.3%) | -$28.18 M(+22.6%) | -$88.59 M(+18.3%) |
| Sep 2022 | - | -$22.98 M(+18.0%) | -$74.91 M(+19.5%) |
| Jun 2022 | - | -$19.48 M(+8.4%) | -$62.66 M(-8.9%) |
| Mar 2022 | - | -$17.96 M(+23.9%) | -$68.74 M(+18.9%) |
| Dec 2021 | -$57.80 M(+175.2%) | -$14.49 M(+35.1%) | -$57.80 M(+23.3%) |
| Sep 2021 | - | -$10.73 M(-58.0%) | -$46.88 M(+1.2%) |
| Jun 2021 | - | -$25.56 M(+264.5%) | -$46.32 M(+92.2%) |
| Mar 2021 | - | -$7.01 M(+95.9%) | -$24.10 M(+14.8%) |
| Dec 2020 | -$21.00 M(+14.0%) | -$3.58 M(-64.8%) | -$21.00 M(+320.3%) |
| Sep 2020 | - | -$10.16 M(+203.7%) | -$5.00 M(-70.3%) |
| Jun 2020 | - | -$3.35 M(-14.4%) | -$16.81 M(+2.4%) |
| Mar 2020 | - | -$3.91 M(-131.5%) | -$16.42 M(-3.5%) |
| Dec 2019 | -$18.41 M | $12.42 M(-156.5%) | -$17.01 M(-51.1%) |
| Sep 2019 | - | -$21.98 M(+644.7%) | -$34.82 M(+75.9%) |
| Jun 2019 | - | -$2.95 M(-34.5%) | -$19.79 M(-17.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$4.51 M(-16.3%) | -$23.97 M(-5.6%) |
| Dec 2018 | -$25.39 M(+8.4%) | -$5.39 M(-22.5%) | -$25.39 M(-1.1%) |
| Sep 2018 | - | -$6.95 M(-2.6%) | -$25.68 M(+6.7%) |
| Jun 2018 | - | -$7.13 M(+20.5%) | -$24.06 M(+5.0%) |
| Mar 2018 | - | -$5.92 M(+4.3%) | -$22.90 M(-2.2%) |
| Dec 2017 | -$23.42 M(-17.6%) | -$5.68 M(+6.6%) | -$23.42 M(-6.5%) |
| Sep 2017 | - | -$5.32 M(-11.0%) | -$25.04 M(-3.5%) |
| Jun 2017 | - | -$5.98 M(-7.1%) | -$25.96 M(-5.6%) |
| Mar 2017 | - | -$6.44 M(-11.8%) | -$27.50 M(-3.3%) |
| Dec 2016 | -$28.43 M(-4.9%) | -$7.30 M(+16.9%) | -$28.43 M(-0.9%) |
| Sep 2016 | - | -$6.24 M(-17.0%) | -$28.71 M(-4.6%) |
| Jun 2016 | - | -$7.52 M(+2.1%) | -$30.09 M(+1.1%) |
| Mar 2016 | - | -$7.37 M(-2.7%) | -$29.76 M(-0.4%) |
| Dec 2015 | -$29.89 M(-6.2%) | -$7.57 M(-0.7%) | -$29.89 M(+4.7%) |
| Sep 2015 | - | -$7.63 M(+6.0%) | -$28.56 M(-20.0%) |
| Jun 2015 | - | -$7.20 M(-4.1%) | -$35.70 M(+3.9%) |
| Mar 2015 | - | -$7.50 M(+20.3%) | -$34.36 M(+7.8%) |
| Dec 2014 | -$31.88 M(+96.5%) | -$6.24 M(-57.8%) | -$31.88 M(+3.0%) |
| Sep 2014 | - | -$14.77 M(+152.5%) | -$30.95 M(+52.4%) |
| Jun 2014 | - | -$5.85 M(+16.5%) | -$20.31 M(+40.5%) |
| Mar 2014 | - | -$5.02 M(-5.5%) | -$14.46 M(+53.2%) |
| Dec 2013 | -$16.22 M(+13.2%) | -$5.31 M(+28.7%) | -$9.44 M(+128.7%) |
| Sep 2013 | - | -$4.13 M | -$4.13 M |
| Dec 2012 | -$14.33 M | - | - |
FAQ
- What is Ocugen annual EBITDA?
- What is the all time high annual EBITDA for Ocugen?
- What is Ocugen annual EBITDA year-on-year change?
- What is Ocugen quarterly EBITDA?
- What is the all time high quarterly EBITDA for Ocugen?
- What is Ocugen quarterly EBITDA year-on-year change?
- What is Ocugen TTM EBITDA?
- What is the all time high TTM EBITDA for Ocugen?
- What is Ocugen TTM EBITDA year-on-year change?
What is Ocugen annual EBITDA?
The current annual EBITDA of OCGN is -$52.79 M
What is the all time high annual EBITDA for Ocugen?
Ocugen all-time high annual EBITDA is -$14.33 M
What is Ocugen annual EBITDA year-on-year change?
Over the past year, OCGN annual EBITDA has changed by +$12.04 M (+18.57%)
What is Ocugen quarterly EBITDA?
The current quarterly EBITDA of OCGN is -$13.24 M
What is the all time high quarterly EBITDA for Ocugen?
Ocugen all-time high quarterly EBITDA is $12.42 M
What is Ocugen quarterly EBITDA year-on-year change?
Over the past year, OCGN quarterly EBITDA has changed by $0.00 (0.00%)
What is Ocugen TTM EBITDA?
The current TTM EBITDA of OCGN is -$52.79 M
What is the all time high TTM EBITDA for Ocugen?
Ocugen all-time high TTM EBITDA is -$4.13 M
What is Ocugen TTM EBITDA year-on-year change?
Over the past year, OCGN TTM EBITDA has changed by $0.00 (0.00%)